Full Press Release Details
Bacterin Annouces Preliminary Second
Second Quarter total revenue in the range of $10.0. million
to $10.2 million, an increase of approximately 12-15% over the same period last year.
Mont. - July 9, 2015 (GLOBE NEWSWIRE) -- Bacterin International
Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications,
today announced preliminary, unaudited revenue for the second quarter of 2015.
The Company is expecting total revenue for the second quarter
of 2015 to be in the range of $10.0 million to $10.2 million, representing an increase of 12-15% when compared to $8.8 million
reported for the second quarter of 2014. This also represents a sequential increase of 5-7% when compared to $9.5 million
for the first quarter of 2015.
The quarterly financial results included in this release were
calculated prior to the completion of a review by Bacterin's external auditors and are therefore subject to adjustment.
About Bacterin International Holdings
Bacterin International Holdings, Inc. (OTCQX:BONE) develops,
manufactures and markets biologics products to domestic and international markets. These products are used in a variety of applications
including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion
of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.
For further information, please visit www.bacterin.com.
Important Cautions Regarding Forward-looking Statements
This news release contains certain disclosures that may be deemed
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to significant
risks and uncertainties. Forward-looking statements include statements that are predictive in nature, that depend upon or refer
to future events or conditions, or that include words such as "continue," "efforts," "expects," "anticipates,"
"intends," "plans," "believes," "estimates," "projects," "forecasts,"
"strategy," "will," "goal," "target," "prospects," "potential," "optimistic,"
"confident," "likely," "probable" or similar expressions or the negative thereof. Statements of historical
fact also may be deemed to be forward-looking statements. We caution that these statements by their nature involve risks and uncertainties,
and actual results may differ materially depending on a variety of important factors, including, among others: the ability of the
Company's sales force to achieve expected results, the Company's ability to meet its existing and anticipated contractual obligations,
including financial covenant and other obligations contained in the Company's secured lending facility; the Company's ability to
manage cash flow; the Company's ability to develop, market, sell and distribute desirable applications, products and services and
to protect its intellectual property; the ability of the Company's customers to pay and the timeliness of such payments; the Company's
ability to obtain financing as and when needed; changes in consumer demands and preferences; the Company's ability to attract and
retain management and employees with appropriate skills and expertise; the impact of changes in market, legal and regulatory conditions
and in the applicable business environment, including actions of competitors; and other factors. Additional risk factors are listed
in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q under the heading "Risk Factors." The
Company undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances
after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.